彩客新能源(01986.HK)附屬山東彩客新材料引資近1.5億人民幣
彩客新能源(01986.HK)公布,為籌備建議分拆,由多方組成的獨立投資者同意以現金出資方式,向山東彩客新材料注資合共1.49億元人民幣,以換取於山東彩客新材料經擴大後約6.62%的股權。於交割後,公司於山東彩客新材料的權益將由原來100%攤薄至約93.38%。
山東彩客新材料主要從事集團主要產品電池材料磷酸鐵的生產及銷售。公司擬將是次增資的所得款項,主要用於補充山東彩客新材料集團的營運資金及/或資本支出;償還截至增資協議簽署日山東彩客新材料與彩客華煜或關聯方之間的借款餘額;及購買銀行委託理財產品且累計購買金額不超過增資所得款項的10%。(ek/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.